JP2023504004A5 - - Google Patents
Info
- Publication number
- JP2023504004A5 JP2023504004A5 JP2022530822A JP2022530822A JP2023504004A5 JP 2023504004 A5 JP2023504004 A5 JP 2023504004A5 JP 2022530822 A JP2022530822 A JP 2022530822A JP 2022530822 A JP2022530822 A JP 2022530822A JP 2023504004 A5 JP2023504004 A5 JP 2023504004A5
- Authority
- JP
- Japan
- Prior art keywords
- agent according
- trapidil
- derivatives
- cognitive impairment
- metabolites
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025047264A JP2025111439A (ja) | 2019-12-02 | 2025-03-21 | トラピジルを使用した認知障害の治療 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962942645P | 2019-12-02 | 2019-12-02 | |
| US62/942,645 | 2019-12-02 | ||
| PCT/US2020/062751 WO2021113266A1 (en) | 2019-12-02 | 2020-12-01 | Treating cognitive disorders using trapidil |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025047264A Division JP2025111439A (ja) | 2019-12-02 | 2025-03-21 | トラピジルを使用した認知障害の治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023504004A JP2023504004A (ja) | 2023-02-01 |
| JP2023504004A5 true JP2023504004A5 (https=) | 2023-12-04 |
| JP7656608B2 JP7656608B2 (ja) | 2025-04-03 |
Family
ID=76221925
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022530822A Active JP7656608B2 (ja) | 2019-12-02 | 2020-12-01 | トラピジルを使用した認知障害の治療 |
| JP2025047264A Pending JP2025111439A (ja) | 2019-12-02 | 2025-03-21 | トラピジルを使用した認知障害の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025047264A Pending JP2025111439A (ja) | 2019-12-02 | 2025-03-21 | トラピジルを使用した認知障害の治療 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220378794A1 (https=) |
| EP (1) | EP4069239A4 (https=) |
| JP (2) | JP7656608B2 (https=) |
| CN (1) | CN115397425A (https=) |
| AU (1) | AU2020398858B2 (https=) |
| CA (1) | CA3163242A1 (https=) |
| WO (1) | WO2021113266A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10695338B2 (en) * | 2015-05-07 | 2020-06-30 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Cancer treatment via repositioned tricyclic anti-depressant-like drugs as anti-cancer agents and new combinations of such drugs |
| MX2022011879A (es) | 2020-03-26 | 2023-01-11 | Sinopia Biosciences Inc | Derivados de trapidilo marcados isotopicamente. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02212488A (ja) * | 1989-02-13 | 1990-08-23 | Shinichiro Shimizu | トリアゾールピリミジン誘導体 |
| AU2004272437A1 (en) | 2003-09-09 | 2005-03-24 | Ono Pharmaceutical Co., Ltd. | CRF antagonists and heterobicyclic compounds |
| WO2012060844A1 (en) * | 2010-11-05 | 2012-05-10 | Biotie Therapies, Inc | A2a antagonists as cognition and motor function enhancers |
| JP7049683B2 (ja) * | 2016-04-04 | 2022-04-07 | シノピア バイオサイエンシーズ，インク． | トラピジルを使用する錐体外路症候群の処置 |
| JP2021524837A (ja) * | 2018-04-13 | 2021-09-16 | ヒールクス リミテッドＨｅａｌｘ Ｌｉｍｉｔｅｄ | 脆弱ｘ症候群のためのキット、組成物および併用療法 |
-
2020
- 2020-12-01 CA CA3163242A patent/CA3163242A1/en active Pending
- 2020-12-01 JP JP2022530822A patent/JP7656608B2/ja active Active
- 2020-12-01 WO PCT/US2020/062751 patent/WO2021113266A1/en not_active Ceased
- 2020-12-01 AU AU2020398858A patent/AU2020398858B2/en active Active
- 2020-12-01 CN CN202080095429.7A patent/CN115397425A/zh active Pending
- 2020-12-01 EP EP20895936.1A patent/EP4069239A4/en active Pending
-
2022
- 2022-06-01 US US17/830,073 patent/US20220378794A1/en active Pending
-
2025
- 2025-03-21 JP JP2025047264A patent/JP2025111439A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2261234T5 (es) | Metabolitos de bupropion y metodos de sintesis y uso. | |
| US8524695B2 (en) | Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same | |
| KR102726728B1 (ko) | 과다 졸림증을 치료하기 위한 방법 및 조성물 | |
| ES2683355T3 (es) | Profármacos de fumaratos y su uso en el tratamiento de diversas enfermedades | |
| US20200179336A1 (en) | Methods of treating neurological and psychiatric disorders | |
| ES2971230T3 (es) | Compuestos inhibidores de VMAT2 y composiciones de los mismos | |
| JP2021505575A (ja) | 非ラセミ混合物およびその使用 | |
| AU2008224869A1 (en) | Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same | |
| JP2021080276A (ja) | デクスメデトミジン製剤を使用する睡眠障害の予防または治療 | |
| JP2011510014A5 (https=) | ||
| JP2023504004A5 (https=) | ||
| WO2018036501A1 (en) | Entacapone-related compounds to treat injury | |
| JP2015180673A (ja) | トランスノルセルトラリン及びセロトニン受容体１ａ作動剤／拮抗剤を含む組成物及びその使用 | |
| JP4970244B2 (ja) | エスゾピクロンを用いる治療方法 | |
| JP2022539152A5 (https=) | ||
| JP2019510826A5 (https=) | ||
| ES2773711T3 (es) | Un metabolito de iloperidona para uso en el tratamiento de trastornos psiquiátricos | |
| WO2019018247A1 (en) | USE OF AMBROXOL TO IMPROVE AND / OR EXTEND THE LIFETIME IN GOOD HEALTH, LIFETIME AND / OR MENTAL ACUITY | |
| JP2023519289A5 (https=) | ||
| CN119235833A (zh) | N-酰基多巴胺家族脂质在防治药物诱导的帕金森病运动并发症中的应用 | |
| CN109640975B (zh) | 组胺-3受体反向激动剂与乙酰胆碱酯酶抑制剂的组合 | |
| CN107073296A (zh) | Mao‑b抑制剂和康复 | |
| US12357619B2 (en) | Noradrenergic and specific serotonergic anxiolytic and antidepressant, method for the production and use thereof | |
| CN112279843B (zh) | 一种具有抗抑郁活性的含氮杂环化合物 | |
| RU2403034C2 (ru) | Применение мадопара для коррекции когнитивных, мотивационных, эмоциональных нарушений у детей с аутистическими расстройствами |